Inventor · disambiguated record
Steven Frey
Also filed as: FREY STEVEN · FREY STEVEN MICHAEL
24 granted patents·1 pending application·221 citations·filing 1995–2025
96Inventor score
Files withTHERACLONE SCIENCES INC12ANTEX BIOLOG INC9CHAN-HUI PO-YING2INT AIDS VACCINE INITIATIVE INC2
Top patents by PatentIndex Score
25 records- 0196US12410243B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2023·Granted Sep 9, 2025·2 cites·16 claims
- 0296US10087239B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2016·Granted Oct 2, 2018·14 cites·7 claims
- 0395US9464131B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2013·Granted Oct 11, 2016·18 cites·4 claims
- 0492US9051362B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityCHAN-HUI PO-YING·Filed 2010·Granted Jun 9, 2015·14 cites·20 claims
- 0591US12312396B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2024·Granted May 27, 2025·0 cites·32 claims
- 0691US11319362B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2019·Granted May 3, 2022·3 cites·44 claims
- 0786US12018067B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2023·Granted Jun 25, 2024·0 cites·29 claims
- 0885US10865234B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Dec 15, 2020·1 cites·7 claims
- 0983US10836811B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2017·Granted Nov 17, 2020·1 cites·4 claims
- 1083US5679564AMethods for producing enhanced antigenic campylobacter bacteria and vaccinesANTEX BIOLOG INC·Filed 1995·Granted Oct 21, 1997·37 cites·12 claims
- 1181US10407493B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Sep 10, 2019·1 cites·20 claims
- 1279US11845789B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2021·Granted Dec 19, 2023·0 cites·15 claims
- 1379US5869066AVaccine containing a campylobacter bacterium having an enhanced antigenic propertyANTEX BIOLOG INC·Filed 1997·Granted Feb 9, 1999·32 cites·16 claims
- 1478US2025320281A1Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2025·Application pending·0 cites
- 1576US11584789B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2020·Granted Feb 21, 2023·0 cites·31 claims
- 1674US8609101B2Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodiesCHAN-HUI PO-YING·Filed 2010·Granted Dec 17, 2013·3 cites·20 claims
- 1773US5681736AMethods for producing enhanced antigenic shigella bacteria and vaccines comprising sameANTEX BIOLOG INC·Filed 1995·Granted Oct 28, 1997·24 cites·13 claims
- 1872US5897475AVaccines comprising enhanced antigenic helicobacter spp.ANTEX BIOLOG INC·Filed 1995·Granted Apr 27, 1999·19 cites·11 claims
- 1969US10239934B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2018·Granted Mar 26, 2019·0 cites·14 claims
- 2063US5858352AVaccine containing a Shigella bacterium having an enhanced antigenic propertyANTEX BIOLOG INC·Filed 1997·Granted Jan 12, 1999·11 cites·16 claims
- 2162US6083683AMethods for detecting shigella bacteria or antibodies to shigella bacteria with an immunoassayANTEX BIOLOG INC·Filed 1999·Granted Jul 4, 2000·13 cites·25 claims
- 2260US9920111B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2015·Granted Mar 20, 2018·0 cites·8 claims
- 2356US6051416AMethods for producing enhanced antigenic Helicobacter sp.ANTEX BIOLOG INC·Filed 1997·Granted Apr 18, 2000·13 cites·19 claims
- 2456US5976525AMethod for producing enhanced antigenic enteric bacteriaANTEX BIOLOG INC·Filed 1997·Granted Nov 2, 1999·7 cites·39 claims
- 2553US6077678AMethods for detecting Campylobacter bacteria or antibodies to Campylobacter bacteria with an immunoassayANTEX BIOLOG INC·Filed 1999·Granted Jun 20, 2000·8 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Steven Frey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →